2021年最新SCI期刊影响因子查询系统
ChemMedChem 期刊详细信息
基本信息
期刊名称 | ChemMedChem ChemMedChem |
---|---|
期刊ISSN | 1860-7179 |
期刊官方网站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187 |
是否OA | 否 |
出版商 | John Wiley and Sons Ltd |
出版周期 | Monthly |
始发年份 | 2006 |
年文章数 | 270 |
最新影响因子 | 3.54(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | CHEMISTRY, MEDICINAL 药物化学3区 | 否 | 否 |
PHARMACOLOGY & PHARMACY 药学3区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 2.51 | 0.880 | 0.754 |
Pharmacology, Toxicology and Pharmaceutics General Pharmacology, Toxicology and Pharmaceutics |
9 / 63 | 86% |
|||
Pharmacology, Toxicology and Pharmaceutics Drug Discovery |
49 / 146 | 66% |
|||
Chemistry Organic Chemistry |
56 / 177 | 68% |
|||
Biochemistry, Genetics and Molecular Biology Molecular Medicine |
86 / 165 | 48% |
|||
Pharmacology, Toxicology and Pharmaceutics Pharmacology |
113 / 300 | 62% |
|||
Biochemistry, Genetics and Molecular Biology Biochemistry |
184 / 407 | 54% |
补充信息
自引率 | 3.20% |
---|---|
H-index | 66 |
SCI收录状况 |
Science Citation Index
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1860-7179%5BISSN%5D |
投稿指南
期刊投稿网址 | http://www.editorialmanager.com/cmdc/default.aspx |
---|---|
收稿范围 | Quality research. Outstanding publications. With an impact factor of 3.016 (2018), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. ChemMedChem is made in Europe, but publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs. |
收录体裁 | Full Papers and Communications Reviews and Minireviews Patent Reviews Highlights and Concepts Book and Multimedia Reviews |
投稿指南 | https://onlinelibrary.wiley.com/page/journal/18607187/homepage/2452_authors.html |
投稿模板 | https://onlinelibrary.wiley.com/page/journal/18607187/homepage/2452_authors.html |
参考文献格式 | https://onlinelibrary.wiley.com/page/journal/18607187/homepage/2452_authors.html |
编辑信息 |